Correlation Between Petros Pharmaceuticals and Sonoma Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Petros Pharmaceuticals and Sonoma Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Petros Pharmaceuticals and Sonoma Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Petros Pharmaceuticals and Sonoma Pharmaceuticals, you can compare the effects of market volatilities on Petros Pharmaceuticals and Sonoma Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Petros Pharmaceuticals with a short position of Sonoma Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Petros Pharmaceuticals and Sonoma Pharmaceuticals.
Diversification Opportunities for Petros Pharmaceuticals and Sonoma Pharmaceuticals
-0.01 | Correlation Coefficient |
Good diversification
The 3 months correlation between Petros and Sonoma is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Petros Pharmaceuticals and Sonoma Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonoma Pharmaceuticals and Petros Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Petros Pharmaceuticals are associated (or correlated) with Sonoma Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonoma Pharmaceuticals has no effect on the direction of Petros Pharmaceuticals i.e., Petros Pharmaceuticals and Sonoma Pharmaceuticals go up and down completely randomly.
Pair Corralation between Petros Pharmaceuticals and Sonoma Pharmaceuticals
Given the investment horizon of 90 days Petros Pharmaceuticals is expected to generate 5.9 times more return on investment than Sonoma Pharmaceuticals. However, Petros Pharmaceuticals is 5.9 times more volatile than Sonoma Pharmaceuticals. It trades about 0.12 of its potential returns per unit of risk. Sonoma Pharmaceuticals is currently generating about -0.14 per unit of risk. If you would invest 31.00 in Petros Pharmaceuticals on October 26, 2024 and sell it today you would earn a total of 4.00 from holding Petros Pharmaceuticals or generate 12.9% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Petros Pharmaceuticals vs. Sonoma Pharmaceuticals
Performance |
| Timeline |
| Petros Pharmaceuticals |
| Sonoma Pharmaceuticals |
Petros Pharmaceuticals and Sonoma Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Petros Pharmaceuticals and Sonoma Pharmaceuticals
The main advantage of trading using opposite Petros Pharmaceuticals and Sonoma Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Petros Pharmaceuticals position performs unexpectedly, Sonoma Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonoma Pharmaceuticals will offset losses from the drop in Sonoma Pharmaceuticals' long position.| Petros Pharmaceuticals vs. Sunshine Biopharma | Petros Pharmaceuticals vs. Sonoma Pharmaceuticals | Petros Pharmaceuticals vs. Alpha Teknova | Petros Pharmaceuticals vs. Evoke Pharma |
| Sonoma Pharmaceuticals vs. China Pharma Holdings | Sonoma Pharmaceuticals vs. Universe Pharmaceuticals | Sonoma Pharmaceuticals vs. Akanda Corp | Sonoma Pharmaceuticals vs. Petros Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |